Skip to main content
Skip to sub-navigation
About USAID Our Work Locations Policy Press Business Careers Stripes Graphic USAID Home
USAID: From The American People Global Partnerships
   GDA Online Database »
   About Alliance Data »
   Legal Guidance »
   Email Comments or Updates »
For Use By USAID Staff Only

Global Development Alliance Database


Please Email Updates or Comments to gda@usaid.gov
 

Alliance Details

Russian Professional Development in HIV/AIDS Medicine
Bureau: ENE  Managed By: Russia 
Initial Year: 2007  Final Year: 2009 
USAID Contact: Olga Frolova  Alliance Location: ENE Regional 
Program Objective:
This public-private partnership aims to train a cadre of health care professionals in state-of-the-art HIV/AIDS treatment and care so that they can serve as experts and leaders in the field. FUNDING PARTNER Glaxo-Smith-Kline (GSK) IMPLEMENTING PARTNER American International Health Alliance (AIHA) This partnership brings the global pharmaceutical company Glaxo-Smith-Kline (GSK) together with the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) to further the professional development of Russian medical specialists in regions most affected by the HIV/AIDS epidemic. Under the project, a core group of clinical leaders will be trained through an intensive two-year fellowship program that will significantly enhance their clinical expertise in HIV medicine. Participants in the fellowship program are selected based on their qualifications and potential to become future leading authorities in the HIV/AIDS field. In particular, their ability and will to educate others—to provide peers with the knowledge and advice needed to build the overall capacity of the Russian HIV-related medical sector—is considered. The project will use an interactive Russian-language Web portal, developed under the EurasiaHealth project, to allow medical professionals to share best practices and to access a library of the latest resources, including treatment guidelines and protocols, textbooks, training materials, and clinical case studies. GlaxoSmithKline and the implementing partner, the American International Health Alliance (AIHA), selected 18 outstanding HIV professionals on a competitive basis to form the core group of experts. As of July 2008, two training workshops had been conducted and the web site had become operational. In addition, AIHA piloted a six-week distance learning course during which 5 clinical case studies were actively discussed online by the selected professionals.

Name Type
GlaxoSmithKline (GSK) Private Business

FYUSAIDPartner
2007 200,000  
2008  207,644 
2009  378,610 
LOP200,000500,000
Countries: Russia
Sectors: HIV/AIDS

 

Back to Top ^

Star